c-Kit inhibitor kit 包含 c-Kit 抑制剂,c-Kit 是一种原癌基因,编码Ⅲ型跨膜受体 Tyr 激酶,通过 Ras-Erk,PI3K-AKT 和 JAK- STAT 三条途径来增加细胞内的信号传导,影响细胞的增殖和存活。多种人类癌症是由 c-Kit 激酶结构域突变引起的,这些突变会破坏 c-Kit 的自抑制机制,导致细胞内的信号通路持续激活,促进肿瘤细胞的发生发展。TargetMol 为您提供40种精选c-Kit 抑制剂。所有化合物现货供应,到货快捷,是您预实验探索的不二选择。
ID | Compound | CAS | MW | Concentration | Target |
---|---|---|---|---|---|
T0093L | Sorafenib | 284461-73-0 | 464.83 | 10mM | Apoptosis; Autophagy; c-Kit; Ferroptosis; FLT; PDGFR; Raf; VEGFR |
T0097L | Pazopanib | 444731-52-6 | 437.52 | 10mM | Autophagy; c-Kit; FGFR; PDGFR; VEGFR |
T0374L | Sunitinib | 557795-19-4 | 398.47 | 10mM | Apoptosis; Autophagy; c-Kit; FLT; IRE1; Mitophagy; PDGFR; VEGFR |
T1448L | Dasatinib monohydrate | 863127-77-9 | 506.03 | 10mM | Apoptosis; Autophagy; Bcr-Abl; c-Kit; Ephrin Receptor; Src |
T1452 | Axitinib | 319460-85-0 | 386.47 | 10mM | c-Kit; PDGFR; VEGFR |
T1667 | Tandutinib | 387867-13-2 | 562.7 | 10mM | Apoptosis; c-Kit; CSF-1R; FLT; PDGFR; Src |
T1792 | Regorafenib | 755037-03-7 | 482.82 | 10mM | Autophagy; c-Kit; c-RET; PDGFR; Raf; VEGFR |
T1836 | AZD2932 | 883986-34-3 | 447.49 | 10mM | c-Kit; FLT; PDGFR; VEGFR |
T2070 | Agerafenib | 1188910-76-0 | 517.46 | 10mM | Bcr-Abl; c-Kit; c-RET; PDGFR; Raf; Src |
T2115 | Pexidartinib | 1029044-16-3 | 417.81 | 10mM | Apoptosis; c-Fms; c-Kit; CSF-1R; FLT |
T2288 | Motesanib | 453562-69-1 | 373.46 | 10mM | c-Kit; VEGFR |
T2500 | Cediranib | 288383-20-0 | 450.51 | 10mM | Autophagy; c-Kit; FLT; PDGFR; VEGFR |
T2516 | Amuvatinib | 850879-09-3 | 447.51 | 10mM | Apoptosis; c-Kit; c-Met/HGFR; c-RET; DNA/RNA Synthesis; FLT; PDGFR |
T2609 | Masitinib | 790299-79-5 | 498.64 | 10mM | Apoptosis; Bcr-Abl; c-Fms; c-Kit; FAK; FGFR; Hck; PDGFR; Src |
T2624 | OSI-930 | 728033-96-3 | 443.44 | 10mM | Apoptosis; c-Fms; c-Kit; CSF-1R; FLT; Raf; Src; VEGFR |
T3452 | ISCK03 | 945526-43-2 | 355.46 | 10mM | c-Kit |
T4315 | Ki20227 | 623142-96-1 | 480.54 | 10mM | c-Fms; c-Kit; CSF-1R; PDGFR; VEGFR |
T4332 | c-Kit-IN-1 | 1225278-16-9 | 489.47 | 10mM | c-Kit; c-Met/HGFR |
T4349 | Sitravatinib | 1123837-84-2 | 629.68 | 10mM | c-Kit; Discoidin Domain Receptor (DDR); Ephrin Receptor; FLT; TAM Receptor; Trk receptor; VEGFR |
T6166 | Telatinib | 332012-40-5 | 409.83 | 10mM | c-Kit; PDGFR; VEGFR |
T6230 | Imatinib | 152459-95-5 | 493.6 | 10mM | Autophagy; Bcr-Abl; c-Kit; PDGFR; SARS-CoV |
T6479 | Dovitinib lactate hydrate | 915769-50-5 | 482.51 | 10mM | c-Kit; FGFR; FLT; PDGFR; VEGFR |
T5109 | Avapritinib | 1703793-34-3 | 498.56 | 10mM | c-Kit; PDGFR; PDGFR |
T5164 | Cabozantinib hydrochloride | 1817759-42-4 | 537.96 | 10mM | c-Kit; c-Met/HGFR; FLT; ROR; TAM Receptor; VEGFR |
T5409 | AZD3229 | 2248003-60-1 | 479.51 | 10mM | c-Kit |
T7394 | Toceranib Phosphate | 874819-74-6 | 494.45 | 10mM | c-Kit; PDGFR; Tyrosinase; VEGFR |
T7861 | Flumatinib mesylate | 895519-91-2 | 658.69 | 10mM | Bcr-Abl; c-Kit; PDGFR |
T7945 | SU14813 | 627908-92-3 | 442.48 | 10mM | c-Kit; PDGFR; VEGFR |
T8482 | Ripretinib | 1442472-39-0 | 510.36 | 10mM | Apoptosis; c-Kit; FLT; PDGFR; VEGFR |
T8541 | Lenvatinib mesylate | 857890-39-2 | 522.96 | 10mM | c-Kit; c-RET; FGFR; PDGFR; VEGFR |
T15199 | Edicotinib | 1142363-52-7 | 461.6 | 10mM | c-Fms; c-Kit; CSF-1R; FLT |
T10157 | Regorafénib N-oxyde (M2) | 835621-11-9 | 498.81 | 10mM | c-Kit; c-RET; Drug Metabolite; PDGFR; Raf; VEGFR |
T12145L | N-Desethylsunitinib hydrochloride | 1261432-05-6 | 406.88 | 10mM | c-Kit; PDGFR; VEGFR |
T22349 | JNJ-38158471 | 951151-97-6 | 364.79 | 10mM | c-Kit; c-RET; VEGFR |
TQ0235 | AC710 | 1351522-04-7 | 562.7 | 10mM | c-Kit; FLT; PDGFR |
T35570 | Chiauranib | 1256349-48-0 | 435.47 | 10mM | VEGFR;PDGFR;c-Kit;Aurora Kinase;c-Fms;FLT |
T41003 | KG5 | 877874-85-6 | 459.45 | 10mM | Raf;PDGFR;FLT;c-Kit |
T10651 | c-Kit-IN-3 | 2363169-01-9 | 516.9 | 10mM | c-Kit |
T9689 | M4205 | 2590556-80-0 | 508.62 | 10mM | c-Kit |
T10803 | CHMFL-KIT-033 | 2351801-41-5 | 415.42 | 10mM | c-Kit |